Showing 641 - 660 results of 910 for search '"Dementia"', query time: 0.05s Refine Results
  1. 641
  2. 642

    MRI imaging characteristics of brainstem and midbrain aqueduct in patients with iNPH by Kui Xiao, Liangxue Zhou, Xielin Tang, Shenghua Liu, Ziang Deng, Feilong Yang

    Published 2025-01-01
    “…Abstract Idiopathic normal pressure hydrocephalus (iNPH) is frequently difficult to diagnose due to the absence of specific symptoms, yet early detection and surgical intervention are essential for preventing sequela such as irreversible dementia. This study explores the specific magnetic resonance imaging (MRI) features of the brainstem and mesencephalic aqueduct in patients with iNPH. …”
    Get full text
    Article
  3. 643

    Human Endogenous Retroviruses and Their Putative Role in Pathogenesis of Alzheimer’s Disease, Inflammation, and Senescence by Patrycja Kozubek, Julia Kuźniar, Magdalena Czaja, Hanna Sitka, Urszula Kochman, Jerzy Leszek

    Published 2024-12-01
    “…Recently research has been focused on the effect of human endogenous retroviruses on the development of neurodegenerative diseases, including Alzheimer’s disease (AD), which is the most common cause of dementia. AD is also linked to a significant deterioration in quality of life. …”
    Get full text
    Article
  4. 644

    Possible influence of sex on the relationship between dual-task gait costs and cognitive decline in older adults. by Monica Christova, Shane Fresnoza, Christoph Palli, Wolfgang Staubmann, Bernhard Guggenberger

    Published 2025-01-01
    “…These underwent Cognitive Functional Dementia (CFD) testing to determine their cognitive abilities and DTG testing to evaluate their gait parameters (gait speed, cadence, stride length, stride variance, and stance phase duration) while performing a backward serial number counting task. …”
    Get full text
    Article
  5. 645

    Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review by Ubaid Ansari, Jimmy Wen, Burhaan Syed, Dawnica Nadora, Romteen Sedighi, Denise Nadora, Vincent Chen, Forshing Lui

    Published 2024-12-01
    “…Furthermore, NP2's involvement in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) emphasizes its broad impact on neuronal health. …”
    Get full text
    Article
  6. 646

    Sensory quiescence induces a cell-non-autonomous integrated stress response curbed by condensate formation of the ATF4 and XRP1 effectors by Shashank Shekhar, Charles Tracy, Peter V. Lidsky, Raul Andino, Katherine J. Wert, Helmut Krämer

    Published 2025-01-01
    “…Abstract Sensory disabilities have been identified as significant risk factors for dementia but underlying molecular mechanisms are unknown. …”
    Get full text
    Article
  7. 647

    A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset by Ján Necpál, Martin Stelzer, Silvia Koščová, Michal Patarák

    Published 2016-01-01
    “…Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized by rapidly progressive dementia along with various neurological features, including myoclonus and sometimes other movement disorders. …”
    Get full text
    Article
  8. 648

    Peripheral proteinopathy in neurodegenerative diseases by Bin Xu, Xia Lei, Ying Yang, Jiayi Yu, Jun Chen, Zhi Xu, Keqiang Ye, Jing Zhang

    Published 2025-01-01
    “…Abstract Proteinopathies in neurology typically refer to pathological changes in proteins associated with neurological diseases, such as the aggregation of amyloid β and Tau in Alzheimer’s disease, α-synuclein in Parkinson’s disease and multiple system atrophy, and TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal dementia. Interestingly, these proteins are also commonly found in peripheral tissues, raising important questions about their roles in neurological disorders. …”
    Get full text
    Article
  9. 649

    Acquired Localized Hypertrichosis Induced by Rivastigmine by Adrian Imbernón-Moya, Sebastian Podlipnik, Fernando Burgos, Elena Vargas-Laguna, Antonio Aguilar-Martínez, Eva Fernández-Cogolludo, Miguel Angel Gallego-Valdes

    Published 2016-01-01
    “…Rivastigmine is a reversible and competitive inhibitor of acetylcholinesterase and butyrylcholinesterase used for symptomatic treatment of Alzheimer dementia and Parkinson’s disease. It has an adequate safety profile and cutaneous side effects are unusual. …”
    Get full text
    Article
  10. 650

    Synthesis, docking, pharmacokinetic prediction, and acetylcholinesterase inhibitory evaluation of N-(2-(piperidine-1-yl)ethyl)benzamide derivatives as potential anti-Alzheimer agen... by Ahmad Mohammadi-Farani, Farzaneh Moradi, Amin Hosseini, Alireza Aliabadi

    Published 2024-12-01
    “…Background and purpose: Alzheimer’s disease is the most common form of dementia and the sixth most common cause of death in the US according to the Alzheimer’s Association. …”
    Get full text
    Article
  11. 651

    Multivariate Analyses with Two-Step Dimension Reduction for an Association Study Between <sup>11</sup>C-Pittsburgh Compound B and Magnetic Resonance Imaging in Alzheimer’s Disease... by Atsushi Kawaguchi, Fumio Yamashita

    Published 2025-01-01
    “…Our method may facilitate the development of a dementia biomarker from brain imaging data. Scoring imaging data allows for visualization and the application of traditional analysis, facilitating clinical analysis for better interpretation of results.…”
    Get full text
    Article
  12. 652

    Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives by Byeong-Hyeon Kim, Sujin Kim, Yunkwon Nam, Yong Ho Park, Seong Min Shin, Minho Moon

    Published 2025-01-01
    “…Abstract Alzheimer’s disease (AD) is the most common type of dementia. Monoclonal antibodies (MABs) serve as a promising therapeutic approach for AD by selectively targeting key pathogenic factors, such as amyloid-β (Aβ) peptide, tau protein, and neuroinflammation. …”
    Get full text
    Article
  13. 653

    Consultations on driving in people with cognitive impairment in primary care: A scoping review of the evidence. by Carol Sinnott, Tony Foley, Justin Forsyth, Kathleen McLoughlin, Linda Horgan, Colin P Bradley

    Published 2018-01-01
    “…<h4>Participants</h4>PCPs or their equivalent and/ or individuals with cognitive impairment across the spectrum of mild cognitive impairment to dementia.<h4>Measurements</h4>Systematic search of Medline, Cinahl, PsychINFO, Academic Search Complete, Psychological and Behavioural Sciences Collection, SocIndex and Social Sciences FT were conducted. …”
    Get full text
    Article
  14. 654

    Relationship between social determinants of health and cognitive performance in an older American population: a cross-sectional NHANES study by Zhen-Guo Yang, Xu Sun, Xue Han, Xiao Wang, Lei Wang

    Published 2025-01-01
    “…Actively investigating the relationship between these factors may be a crucial strategy for delaying dementia onset.…”
    Get full text
    Article
  15. 655

    Dietary Fatty Acids and Predementia Syndromes by Vincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, Alessia D' Introno, Anna M. Colacicco, Gianluigi Vendemiale, Antonio Capurso, Francesco Panza

    Published 2009-01-01
    “…Therefore, at present, no definitive dietary recommendations on fish and unsaturated fatty acids consumption, or lower intake of saturated fat, in relation to the risk for dementia and cognitive decline are possible.…”
    Get full text
    Article
  16. 656

    Transformative Service Research and the role of service robots: a bibliometric analysis by Priscila Pasti Barbosa, Felipe Facco Mendes Ferreira, Larissa Cayla Cesário, Glauco Henrique de Souza Mendes

    Published 2025-01-01
    “…The analysis of several use cases of service robots in elderly care is carried out in the article to highlight the importance of using this service in cases of great importance, such as in cases of dementia. Cultural sensitivity and personalization of robots emerged as essential factors for increasing user acceptance and scalability, particularly in diverse healthcare environments. …”
    Get full text
    Article
  17. 657

    Estimating the potential health effects of cleaner air in the initial stages of the COVID-19 pandemic: a study in Malmö, Sweden by Ebba Malmqvist, Emilie Stroh, Erin Flanagan, Christina Isaxon, Pontus Roldin, Anna Oudin

    Published 2024-12-01
    “…If sustained, such improvements could lead to an estimated 1–3% decrease in premature deaths, a 2% decrease in preeclampsia cases, a 6% decrease in low birthweight children, a 4% decrease in bronchitis cases among children, a 2% decrease in asthma cases, a 0.2% decrease in hospital admissions for respiratory diagnoses, and an estimated 11% decrease in dementia cases annually. Conclusion The findings illustrate the potential for enhanced health in Malmö due to improved air quality. …”
    Get full text
    Article
  18. 658

    Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions by Grace Kuo, Ramhari Kumbhar, William Blair, Valina L. Dawson, Ted M. Dawson, Xiaobo Mao

    Published 2025-01-01
    “…Abstract α-Synucleinopathies constitute a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD), Lewy body dementia (LBD), Multiple System Atrophy (MSA), and Alzheimer’s disease concurrent with LBD (AD-LBD). …”
    Get full text
    Article
  19. 659

    Impact of Alzheimer’s Disease on Caregivers in the United States by Megan Vu, Rohan Mangal, Thor Stead, Carlos Lopez-Ortiz, Latha Ganti

    Published 2022-08-01
    “…As patients’ symptoms of dementia continue to worsen, they gradually grow more limited in their independence. …”
    Get full text
    Article
  20. 660

    Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review by Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei, Seyran Kakebaraei

    Published 2023-05-01
    “…Abstract Alzheimer's disease (AD) is one of the chief neurological difficulties in the aged population, identified through dementia, memory disturbance, and reduced cognitive abilities. β‐amyloid (Aβ) plaques aggregations, generation of reactive oxygen species, and mitochondrial dysfunction are among the major signs of AD. …”
    Get full text
    Article